Featured Research

from universities, journals, and other organizations

Personalised therapy reduces the risk of cardiovascular disease for diabetics

Date:
October 8, 2013
Source:
Medical University of Vienna
Summary:
600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy. This group accounts for around 40 per cent of all diabetics.

600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy. This group accounts for around 40 per cent of all diabetics. Researchers at the University Departments of General Medicine II and III at the MedUni Vienna have now demonstrated that high-dose, personalised therapy with ACE inhibitors and beta blockers can significantly reduce the risk of cardiac disease among affected patients -- by as much as 64 per cent.

300 patients with diabetes mellitus and elevated NT-proBNP levels who had no history of heart disease took part in the Pontiac study, the results of which have now been published in the top journal "Journal of the American College of Cardiology." The study, which was carried out in collaboration with the MedUni Vienna's Clinical Department of Endocrinology and Metabolic Medicine and Clinical Department of Cardiology, along with the 3rd Department of Medicine at Hietzing Hospital and the health centres in central and south Vienna, involved 150 patients who were randomised to the intervention group and 150 patients who were randomised to the control group.

"In the intervention group, in addition to the diabetes treatment being given in accordance with treatment guidelines, RAAS antagonists that were already being prescribed were increased to the maximum permitted dose, while at the same time patients were given the maximum possible dose of a cardioselective beta blocker," explains Martin Clodi from the University Department of General Medicine III at the MedUni Vienna, who, together with Richard Pacher and Martin Hόlsmann (General Medicine II), is one of the senior authors of the study. The 150 patients in the control group were given treatment that complies with the currently applicable guidelines set down by the Austrian Diabetes Society.

The striking result was that, in the intervention group, it was demonstrated that high-dose RAAS antagonists, in combination with beta blockers, can reduce the risk of cardiovascular events by 64 percent. "The results strongly indicate, with all due safety considerations, the excellent effectiveness of biomarker-led, personalised therapy," says Clodi, and Pacher adds: "This is the first primary preventative study approach for the successful prophylaxis of cardiac disease in diabetics."


Story Source:

The above story is based on materials provided by Medical University of Vienna. Note: Materials may be edited for content and length.


Journal Reference:

  1. Martin Huelsmann, Stephanie Neuhold, Michael Resl, Guido Strunk, Helmut Brath, Claudia Francesconi, Christopher Adlbrecht, Rudolf Prager, Anton Luger, Richard Pacher, Martin Clodi. PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease). Journal of the American College of Cardiology, 2013; 62 (15): 1365 DOI: 10.1016/j.jacc.2013.05.069

Cite This Page:

Medical University of Vienna. "Personalised therapy reduces the risk of cardiovascular disease for diabetics." ScienceDaily. ScienceDaily, 8 October 2013. <www.sciencedaily.com/releases/2013/10/131008091245.htm>.
Medical University of Vienna. (2013, October 8). Personalised therapy reduces the risk of cardiovascular disease for diabetics. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2013/10/131008091245.htm
Medical University of Vienna. "Personalised therapy reduces the risk of cardiovascular disease for diabetics." ScienceDaily. www.sciencedaily.com/releases/2013/10/131008091245.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) — A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) — The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) — After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) — Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins